{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:46:47Z","timestamp":1788270407880,"version":"build-2803163510"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Tiaoganquzhi Decoction (TGQZD) is a traditional Chinese herbal formulation demonstrated to be a clinically effective treatment for nonalcoholic fatty liver disease (NAFLD), although details concerning its clinical mechanism are poor. This study aimed to explore the mechanism of TGQZD on improvement of inflammatory damage and dyslipidemia caused by NAFLD through the CGI-58\/ROS\/NLRP3 inflammasome pathway. In our research, the <jats:italic>in vivo<\/jats:italic> protective effects of TGQZD on HFD-induced liver injury in rats and <jats:italic>in vitro<\/jats:italic> using lipopolysaccharide (LPS)+palmitate (PA)-stimulated HepG-2 cells model. Histological changes were evaluated by hematoxylin-eosin and Oil Red O staining. Inflammatory cytokines and protein expression were analyzed by ELISA, Real time PCR and western blotting. Liver function, blood lipids, free fatty acids (FFA), and reactive oxygen species (ROS) were determined by biochemical detection. Our results indicated that TGQZD exhibited anti-inflammatory activity, reduced the severity of NAFLD and ameliorated the pathological changes. Further, TGQZD improved liver function and lipid metabolism in NAFLD rats. TGQZD lowered serum aspartate aminotransferase, alanine aminotransferase, triglyceride, and total cholesterol levels. TGQZD suppressed the formulation of FFA and ROS. It also reduced the expression and release of the inflammatory cytokine interleukin-1\u03b2 by promoting CGI-58 expression and inhibiting the expression of FFA, TNF-\u03b1, and the NLRP3 inflammasome induced by ROS. TGQZD exhibited anti-inflammatory effects via the CGI-58, ROS and NLRP3 inflammasome pathway <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>, respectively. Our findings demonstrated that TGQZD is a useful and effective therapeutic agent for treating NAFLD via promotion of CGI-58 to inhibit the expression of ROS-induced NLRP3 inflammasome.<\/jats:p>","DOI":"10.3389\/fphar.2022.851267","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T05:38:01Z","timestamp":1651469881000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome"],"prefix":"10.3389","volume":"13","author":[{"given":"Huicun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/hep.28776","article-title":"Novel Plasma Biomarkers Associated with Liver Disease Severity in Adults with Nonalcoholic Fatty Liver Disease","volume":"65","author":"Ajmera","year":"2017","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3746\/pnf.2016.21.1.14","article-title":"Ameliorative Effects of Pomegranate Peel Extract against Dietary-Induced Nonalcoholic Fatty Liver in Rats","volume":"21","author":"Al-Shaaibi","year":"2016","journal-title":"Prev. Nutr. Food Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic Steatohepatitis: an Expanded Clinical Entity","volume":"107","author":"Bacon","year":"1994","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1677\/JOE-07-0234","article-title":"Infliximab Reverses Steatosis and Improves Insulin Signal Transduction in Liver of Rats Fed a High-Fat Diet","volume":"194","author":"Barbuio","year":"2007","journal-title":"J. Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1194\/jlr.M010256","article-title":"CGI-58 Knockdown in Mice Causes Hepatic Steatosis but Prevents Diet-Induced Obesity and Glucose Intolerance","volume":"51","author":"Brown","year":"2010","journal-title":"J. Lipid Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1194\/jlr.M700279-JLR200","article-title":"CGI-58 Facilitates the Mobilization of Cytoplasmic Triglyceride for Lipoprotein Secretion in Hepatoma Cells","volume":"48","author":"Brown","year":"2007","journal-title":"J. Lipid Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.amjcard.2018.10.027","article-title":"Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance","volume":"123","author":"Canada","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Am. Assoc. Study LiverGastroenterology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of Oxidative Stress in the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/hep.24696","article-title":"Should Combination Therapy Be the Paradigm for Future Nonalcoholic Steatohepatitis Clinical Trials?","volume":"54","author":"Corey","year":"2011","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/s0016-5085(98)70599-2","article-title":"Steatohepatitis: a Tale of Two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate Immune Activation through Nalp3 Inflammasome Sensing of Asbestos and Silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3892\/ijmm.2020.4479","article-title":"CYP4A11 Is Involved in the Development of Nonalcoholic Fatty Liver Disease via ROS-induced Lipid Peroxidation and Inflammation","volume":"45","author":"Gao","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3760\/cma.j.issn.1007-3418.2016.12.019","article-title":"NACHT-LRR-PYD-containing Proteins 3 Inflammasome and Nonalcoholic Fatty Liver Disease","volume":"24","author":"Gao","year":"2016","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3892\/ijmm.2019.4234","article-title":"Excess Fructose and Fatty Acids Trigger a Model of Nonalcoholic Fatty Liver Disease Progression In Vitro: Protective Effect of the Flavonoid Silybin","volume":"44","author":"Grasselli","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/nu12051450","article-title":"Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance","volume":"12","author":"Hasegawa","year":"2020","journal-title":"Nutrients"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/nu11092062","article-title":"Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/13543784.2020.1668926","article-title":"Multi-drug Approaches to NASH: What's in the Development Pipeline?","volume":"29","author":"Johnston","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/ni.2668","article-title":"NLRP3 Inflammasome Activation: CD36 Serves Double Duty","volume":"14","author":"Kagan","year":"2013","journal-title":"Nat. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/1750-3841.13777","article-title":"Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet","volume":"82","author":"Kim","year":"2017","journal-title":"J. Food Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and Validation of a Histological Scoring System for Nonalcoholic Fatty Liver Disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cmet.2006.03.005","article-title":"Adipose Triglyceride Lipase-Mediated Lipolysis of Cellular Fat Stores Is Activated by CGI-58 and Defective in Chanarin-Dorfman Syndrome","volume":"3","author":"Lass","year":"2006","journal-title":"Cell Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"12787","DOI":"10.3748\/wjg.v21.i45.12787","article-title":"Peroxisome Proliferator-Activated Receptor-delta Agonist Ameliorated Inflammasome Activation in Nonalcoholic Fatty Liver Disease","volume":"21","author":"Lee","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1086\/324121","article-title":"Mutations in CGI-58, the Gene Encoding a New Protein of the Esterase\/lipase\/thioesterase Subfamily, in Chanarin-Dorfman Syndrome","volume":"69","author":"Lef\u00e8vre","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.metabol.2017.11.002","article-title":"Nicotinic Acetylcholine Receptor \u03b17 Subunit Improves Energy Homeostasis and Inhibits Inflammation in Nonalcoholic Fatty Liver Disease","volume":"79","author":"Li","year":"2018","journal-title":"Metabolism"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1016\/j.apsb.2021.03.018","article-title":"Integrative Lipidomic and Transcriptomic Study Unravels the Therapeutic Effects of Saikosaponins A and D on Non-alcoholic Fatty Liver Disease","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin B"},{"key":"B28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbadis.2017.10.016","article-title":"Inhibition of EGFR Attenuates Fibrosis and Stellate Cell Activation in Diet-Induced Model of Nonalcoholic Fatty Liver Disease","volume":"1864","author":"Liang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12944-016-0194-7","article-title":"Free Fatty Acids, Not Triglycerides, Are Associated with Non-alcoholic Liver Injury Progression in High Fat Diet Induced Obese Rats","volume":"15","author":"Liu","year":"2016","journal-title":"Lipids Health Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4161\/adip.20035","article-title":"Distinct Roles for Alpha-Beta Hydrolase Domain 5 (ABHD5\/CGI-58) and Adipose Triglyceride Lipase (ATGL\/PNPLA2) in Lipid Metabolism and Signaling","volume":"1","author":"Lord","year":"2012","journal-title":"Adipocyte"},{"key":"B31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.celrep.2016.06.049","article-title":"Regulation of Hepatic Triacylglycerol Metabolism by CGI-58 Does Not Require ATGL Co-activation","volume":"16","author":"Lord","year":"2016","journal-title":"Cell Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"108753","DOI":"10.1016\/j.biopha.2019.108753","article-title":"Ferulic Acid Ameliorates Nonalcoholic Fatty Liver Disease and Modulates the Gut Microbiota Composition in High-Fat Diet Fed ApoE (-\/-) Mice","volume":"113","author":"Ma","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1084\/jem.20030299","article-title":"IL-1 Plays an Important Role in Lipid Metabolism by Regulating Insulin Levels under Physiological Conditions","volume":"198","author":"Matsuki","year":"2003","journal-title":"J. Exp. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.celrep.2014.02.047","article-title":"Macrophage CGI-58 Deficiency Activates ROS-Inflammasome Pathway to Promote Insulin Resistance in Mice","volume":"7","author":"Miao","year":"2014","journal-title":"Cel Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A Simple Practice Guide for Dose Conversion between Animals and Human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"B37","volume-title":"Professor Wei Beihai's Academic Thought and Clinical Experience Summary and Clinical Research on the Treatment of Non-alcoholic Fatty Hepatitisdoctor Doctor","author":"Qi","year":"2012"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11010-012-1416-6","article-title":"Increase of Autophagy and Attenuation of Apoptosis by Salvigenin Promote Survival of SH-Sy5y Cells Following Treatment with H\u2082O\u2082","volume":"371","author":"Rafatian","year":"2012","journal-title":"Mol. Cel Biochem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1038\/s41598-019-45009-1","article-title":"Environmental Microcystin Targets the Microbiome and Increases the Risk of Intestinal Inflammatory Pathology via NOX2 in Underlying Murine Model of Nonalcoholic Fatty Liver Disease","volume":"9","author":"Sarkar","year":"2019","journal-title":"Sci. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/antiox10071042","article-title":"Salvigenin, a Trimethoxylated Flavone from Achillea Wilhelmsii C. Koch, Exerts Combined Lipid-Lowering and Mitochondrial Stimulatory Effects","volume":"10","author":"Serino","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1864307","DOI":"10.1155\/2018\/1864307","article-title":"Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL\/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway","volume":"2018","author":"Shao","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"B42","doi-asserted-by":"publisher","first-page":"5023157","DOI":"10.1155\/2020\/5023157","article-title":"The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods","volume":"2020","author":"Soresi","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"18070","DOI":"10.3748\/wjg.v20.i48.18070","article-title":"Adipokines and Proinflammatory Cytokines, the Key Mediators in the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"20","author":"Stojsavljevic","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cld.2009.07.003","article-title":"Apoptosis and Cytokines in Non-alcoholic Steatohepatitis","volume":"13","author":"Syn","year":"2009","journal-title":"Clin. Liver Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/iub.2221","article-title":"Inhibiting miR-27a and miR-142-5p Attenuate Nonalcoholic Fatty Liver Disease by Regulating Nrf2 Signaling Pathway","volume":"72","author":"Teimouri","year":"2020","journal-title":"IUBMB Life"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: the Multiple Parallel Hits Hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/hep.28456","article-title":"Interleukin-1 and Inflammasomes in Alcoholic Liver Disease\/acute Alcoholic Hepatitis and Nonalcoholic Fatty Liver Disease\/nonalcoholic Steatohepatitis","volume":"64","author":"Tilg","year":"2016","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1053\/gast.2002.31065","article-title":"Tumor Necrosis Factor Alpha Promoter Polymorphisms and Insulin Resistance in Nonalcoholic Fatty Liver Disease","volume":"122","author":"Valenti","year":"2002","journal-title":"Gastroenterology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6489012","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12944-020-01210-0","article-title":"Mutual Interaction between Endoplasmic Reticulum and Mitochondria in Nonalcoholic Fatty Liver Disease","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty Acid-Induced NLRP3-ASC Inflammasome Activation Interferes with Insulin Signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The Role of Small Intestinal Bacterial Overgrowth, Intestinal Permeability, Endotoxaemia, and Tumour Necrosis Factor Alpha in the Pathogenesis of Non-Alcoholic Steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"B53","doi-asserted-by":"publisher","first-page":"754976","DOI":"10.3389\/fphar.2021.754976","article-title":"Ferulic Acid Ameliorates Hepatic Inflammation and Fibrotic Liver Injury by Inhibiting PTP1B Activity and Subsequent Promoting AMPK Phosphorylation","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/pin.12634","article-title":"Peroxiredoxin 4 (PRDX4): Its Critical In Vivo Roles in Animal Models of Metabolic Syndrome Ranging from Atherosclerosis to Nonalcoholic Fatty Liver Disease","volume":"68","author":"Yamada","year":"2018","journal-title":"Pathol. Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/13880209.2021.1928240","article-title":"Effects of Jian Pi Qing Chang Hua Shi Decoction on Mucosal Injuries in a 2,4,6-trinitrobenzene Sulphonic Acid-Induced Inflammatory Bowel Disease Rat Model","volume":"59","author":"Zhang","year":"2021","journal-title":"Pharm. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A Role for Mitochondria in NLRP3 Inflammasome Activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"9892","DOI":"10.1074\/jbc.M112.420620","article-title":"Functional Cardiac Lipolysis in Mice Critically Depends on Comparative Gene Identification-58","volume":"288","author":"Zierler","year":"2013","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.851267\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T05:38:03Z","timestamp":1651469883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.851267\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":57,"alternative-id":["10.3389\/fphar.2022.851267"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.851267","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"article-number":"851267"}}